"Everything about it I thought was super cool. Very current, I could tell how difficult it was, and it just got better and better," Simon Cowell shared.

Dai-ichi Life Holdings Inc will take a 15.1 percent stake in an Australian life insurer, aiming to expand its overseas reach to offset the shrinking domestic market constrained by Japan's declining ...

Gut Microbiota in Immuno-Oncology: A Practical Guide for Medical Oncologists With a Focus on Antibiotics Stewardship Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, ...

A deal has reportedly been agreed for the £25million sale of Reading to save the club from administration and potential expulsion from the EFL. Rob Couhig has apparently revived his offer to ...

Following its demutualization and IPO in 2010, Daiichi Life Group has transformed from one of Japan’s big four traditional life insurers to a multinational holding company with a multibrand ...

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company ...

MS&AD Insurance Group Holdings Inc has reached a deal to sell its full equity holding in Challenger Ltd, an Australian annuities and investment management firm, to TAL Dai-ichi Life Australia Pty ...

Japanese life insurer Dai-ichi Life Holdings Inc. will take a 15.1% stake in an Australian life insurer Challenger. Archived articles are available to Magazine subscribers only. If you are already a ...

However, there is a view that there is more to the transaction. The deal involved Dai-ichi buying the stake at $8.46 a share, outlaying about $884m, at a 53 per cent premium to Challenger’s ...

Japanese insurance group MS&AD Insurance Holdings, the parent of the Mitsui Sumitomo insurance entities, has agreed to sell all of its shares in Australian financial services company with annuities ...

The drug, which is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC), was discovered by Japan’s Daiichi Sankyo (TYO: 4568) and is being jointly developed and commercialized by ...